Welcome to this site and thank you for taking an interest in our research.
Please find above the navigation bar should you wish to access further details.
Alternatively should you wish to contact me directly, please find my contact details below.
Professor Celine J. Marmion
Department of Pharmaceutical & Medicinal Chemistry
Royal College of Surgeons in Ireland
123 St. Stephen's Green
Tel: 353 1 4022161
Check out our review on 'Exploiting Developments in Nanotechnology for the Preferential Delivery of Platinum-Based Anti-Cancer Agents to Tumours: Targeting Some of the Hallmarks of Cancer' in Metallomics, 2016, 20, 8, (1), 43-60 (PMID: 26567482). It was chosen by the editor as a hot article and was one of the top 20 most downloaded articles published in 2016. See the Metallomics Themed Collection: http://pubs.rsc.org/en/journals/articlecollectionlanding?sercode=mt&themeid=26be02e4-6298-40f7-b7bb-29efc3cc408a
Congratulations to Ziga Ude who graduated with a PhD in November 2016.
Congratulations to Dr Tadhg McGivern who successfully completed his PhD and graduated in June 2016. Tadhg delivered the valedictorian address at the graduation ceremony!
Kenny, R.G., Chuah, S.W., Crawford, A., Marmion, C.J. Platinum (IV) Prodrugs - A Step Closer to Ehrlich's Vision?, Eur. J. Inorg. Chem., 2016 available online DOI: 10.1002/ejic.201601278 (by invitation)
Parker, J.P., Devocelle, M., Morgan, M.P., Marmion, C.J.* Derivatisation of buforin IIB, a cationic henicosapeptide, to afford its complexation to platinum(II) resulting in a novel platinum(II)-buforin IIb conjugate with anti-cancer activity. Dalton Trans., 2016, 45, 13038 - 13041(Communication) PMID: 27292799
Ude, Z., Romero-Canelon, I., Twamley, B., Fitzgerald Hughes, D., Sadler, P.J.*, Marmion, C.J.* A Novel Dual-Functioning Ruthenium(II)-Arene Complex of an Anti-microbial Ciprofloxacin Derivative - Anti-proliferative and Anti-microbial J. Inorg. Biochem., 2016, 160, 210-217 PMID: 26993079 (Open Access)
Parker, J.P., Ude, Z., Marmion, C.J.*, Exploiting Developments in Nanotechnology for the Preferential Delivery of Platinum-Based Anti-Cancer Agents to Tumours: Targeting Some of the Hallmarks of Cancer, Metallomics, 2016, 8, 1, 43-60 PMID: 2656748